Director Comey Speaks on San Bernardino Investigation
December 4, 2015
Following the recent act of terrorism in San Bernardino, California, FBI Director James Comey urges Americans to forbid fear from disabling them.
Mollie Halpern: Following the recent act of terrorism in San Bernardino, California, FBI Director James Comey urges Americans to forbid fear from disabling them.
Director James Comey: Please channel that sense of fear into something healthy, just an awareness of your surroundings, and let us do the work that you pay us to do, which is to investigate and fight terrorism while you live the lives that are so wonderful in this great country of ours.
Halpern: Director Comey encourages the public to contact the FBI or local law enforcement when they suspect something or someone.
Comey: We have worked very, very hard since 9/11 to get ourselves to a place where if you tell a police officer or a deputy sheriff or call the FBI and say, "You know, I saw something next door that seems off," or, "I saw something online that seems off," it will get to the right people. And we will investigate it quickly and responsibly.
Halpern: The FBI is leading the terrorism investigation into the mass shooting and has hundreds of people around the world looking into every detail of the case.
Director Comey says his heart aches for the victims and their families. He also offers his gratitude to those who responded—everyone from police to…
Comey: …the EMTs, the docs, the nurses, the victim specialists. Those are people who are the angels of our business and don’t get the thanks they deserve. So, thank you to them.
Halpern: I’m Mollie Halpern of the Bureau with FBI, This Week.
- 08.17.2017 — FBI, This Week: Bureau Trains with Partners on Indian Country Crime
- 08.10.2017 — Inside the FBI: Internet-Connected Toys Pose Security Risks
- 08.10.2017 — FBI, This Week: Internet-Connected Toys Pose Security Risks
- 08.03.2017 — FBI, This Week: Christopher Wray Sworn In as FBI Director
- 07.27.2017 — FBI, This Week: One-Year Anniversary of Prescription Drug Initiative